News
-
-
-
-
-
REGULATED PRESS RELEASE
Compagnie Chargeurs Invest : Study of a potential sale of Novacel following several indicative expressions of interest
Chargeurs considers potential sale of Novacel following indicative expressions of interest for Innovative Materials platform, aligning with active portfolio management strategy -
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases the total number of shares (92,185,473 ordinary shares, 6,419 Preferred Shares 2016, 7,581 Preferred Shares 2017) and voting rights (92,962,943 theoretical, 92,944,368 exercisable) as of September 1, 2025 in compliance with regulations -
-
-